Close Menu

NEW YORK – Researchers at Rutgers University have developed a point-of-care diagnostic device that uses multifrequency impedance spectroscopy and supervised machine learning to measure the effect of chemotherapeutic agents on cancer cells. According to a new study published in Microsystems and Nanoengineering, the device rapidly assesses the sensitivity of tumor cells to the drugs they're exposed to without the need for staining or labeling the cells.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.